SERPINA3 and Alzheimer disease: This, however, contrasts the report of Zhou et al. (2020), who did not detect reactive OLs in human AD samples using snRNA-seq, or Chen et al. (2020), who screened plaque regions for C4A/C4B and SERPINA3 transcripts by in situ sequencing (ISS).